These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 36774332)

  • 1. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis.
    Watanabe A; Iwagami M; Yasuhara J; Takagi H; Kuno T
    Vaccine; 2023 Mar; 41(11):1783-1790. PubMed ID: 36774332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis.
    Watanabe A; Kani R; Iwagami M; Takagi H; Yasuhara J; Kuno T
    JAMA Pediatr; 2023 Apr; 177(4):384-394. PubMed ID: 36689319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis.
    Gao P; Liu J; Liu M
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients.
    Peghin M; De Martino M; Palese A; Gerussi V; Bontempo G; Graziano E; Visintini E; D'Elia D; Dellai F; Marrella F; Fabris M; Curcio F; Sartor A; Isola M; Tascini C
    Clin Microbiol Infect; 2022 Aug; 28(8):1140-1148. PubMed ID: 35339673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study.
    Augustin M; Stecher M; Wüstenberg H; Di Cristanziano V; Sandaradura de Silva U; Picard LK; Pracht E; Rauschning D; Gruell H; Klein F; Wenisch C; Hallek M; Schommers P; Lehmann C
    Front Immunol; 2023; 14():1226622. PubMed ID: 37781408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis.
    Ceban F; Kulzhabayeva D; Rodrigues NB; Di Vincenzo JD; Gill H; Subramaniapillai M; Lui LMW; Cao B; Mansur RB; Ho RC; Burke MJ; Rhee TG; Rosenblat JD; McIntyre RS
    Brain Behav Immun; 2023 Jul; 111():211-229. PubMed ID: 36990297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study).
    Arashiro T; Arima Y; Muraoka H; Sato A; Oba K; Uehara Y; Arioka H; Yanai H; Kuramochi J; Ihara G; Chubachi K; Yanagisawa N; Nagura Y; Kato Y; Ueda A; Numata A; Kato H; Ishii K; Ooki T; Oka H; Nishida Y; Stucky A; Smith C; Hibberd M; Ariyoshi K; Suzuki M
    Clin Infect Dis; 2023 Feb; 76(3):e108-e115. PubMed ID: 35918782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.
    Becerril-Gaitan A; Vaca-Cartagena BF; Ferrigno AS; Mesa-Chavez F; Barrientos-Gutiérrez T; Tagliamento M; Lambertini M; Villarreal-Garza C
    Eur J Cancer; 2022 Jan; 160():243-260. PubMed ID: 34794855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis.
    Ssentongo P; Ssentongo AE; Voleti N; Groff D; Sun A; Ba DM; Nunez J; Parent LJ; Chinchilli VM; Paules CI
    BMC Infect Dis; 2022 May; 22(1):439. PubMed ID: 35525973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials.
    Yang ZR; Jiang YW; Li FX; Liu D; Lin TF; Zhao ZY; Wei C; Jin QY; Li XM; Jia YX; Zhu FC; Yang ZY; Sha F; Feng ZJ; Tang JL
    Lancet Microbe; 2023 Apr; 4(4):e236-e246. PubMed ID: 36868258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    Efe C; Taşçılar K; Gerussi A; Bolis F; Lammert C; Ebik B; Stättermayer AF; Cengiz M; Gökçe DT; Cristoferi L; Peralta M; Massoumi H; Montes P; Cerda E; Rigamonti C; Yapalı S; Adali G; Çalışkan AR; Balaban Y; Eren F; Eşkazan T; Barutçu S; Lytvyak E; Zazueta GM; Kayhan MA; Heurgue-Berlot A; De Martin E; Yavuz A; Bıyık M; Narro GC; Duman S; Hernandez N; Gatselis NK; Aguirre J; Idilman R; Silva M; Mendizabal M; Atay K; Güzelbulut F; Dhanasekaran R; Montano-Loza AJ; Dalekos GN; Ridruejo E; Invernizzi P; Wahlin S
    J Autoimmun; 2022 Oct; 132():102906. PubMed ID: 36088883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.